MacroGenics, Inc.

MGNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Assets
Cash & Equivalents $211.7M $84.1M $196.2M $157.6M $116.5M $47.7M
Accounts Receivable $13.6M $2.8M $1.2M $2.9M $2.0M $2.0M
Inventory — — — — — —
Total Current Assets $322.3M $283.9M $342.4M $164.7M $119.5M $49.9M
Property, Plant & Equipment $50.0M $18.0M $14.8M $6.8M $5.0M $3.3M
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — —
Total Assets $373.9M $311.3M $359.3M $173.9M $125.8M $53.7M
Liabilities
Accounts Payable $2.5M $4.0M $3.0M $1.7M $3.2M $3.7M
Total Current Liabilities $49.8M $27.3M $24.2M $27.1M $28.8M $29.7M
Long-Term Debt — — — — — —
Total Liabilities $74.6M $42.5M $45.9M $52.6M $46.9M $62.0M
Stockholders' Equity
Retained Earnings $-312.3M $-292.7M $-234.2M $-214.0M $-175.7M $-175.5M
Total Stockholders' Equity $299.2M $268.8M $313.3M $121.3M $78.9M $-8.2M
← Newer Page 2 of 2 Older →